Multiple Choice
While on testosterone replacement, hemoglobin and hematocrit levels should be monitored. Levels suggestive of excessive erythrocytosis or abuse are:
A) Hemoglobin 14 g/dl or hematocrit 39%
B) Hemoglobin 11.5 g/dl or hematocrit 31%
C) Hemoglobin 13 g/dl or hematocrit 38%
D) Hemoglobin 17.5 g/dl or hematocrit 54%
Correct Answer:

Verified
Correct Answer:
Verified
Q1: Men who are prescribed phosphodiesterase type 5
Q2: Male patients who should not be prescribed
Q3: The factor that has the greatest effect
Q4: Some research supports that testosterone replacement therapy
Q6: The goal of testosterone replacement therapy is:<br>A)
Q7: Monitoring of an older male patient on
Q8: Monitoring of male patients who are using
Q9: When prescribing phosphodiesterase type 5 (PDE-5) inhibitors
Q10: When assessing a male for hypogonadism prior